Identifying and addressing underuse in hematologic care through systems-based hematology
Underuse of high-value hematologic care receives comparatively less attention than the overuse of unnecessary tests and treatments. In this review, we analyze examples of underutilized care in several domains: procedural (inferior vena cava filter retrieval), medical (hydroxyurea use in sickle cell...
Saved in:
| Main Authors: | Jacob C. Cogan, Allison E. Burnett, Alexandra Power-Hays, Geoffrey D. Barnes, Ming Y. Lim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037925002055 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence of avascular necrosis in patients with sickle cell anemia received hydroxyurea and blood transfusion: a comparative study
by: Asmaa Hassan Khudhair, et al.
Published: (2024-12-01) -
Influence of hydroxyurea on tubular phosphate handling in sickle cell nephropathy
by: Gabriela Araujo de Abreu, et al.
Published: (2024-11-01) -
Editorial: Medical overuse and underuse in healthcare systems
by: Morteza Arab-Zozani, et al.
Published: (2025-04-01) -
Sickle Cell Anemia Treatment With Hydroxyurea in Low-Resource Settings: Challenges and Opportunities for Global North-South Collaboration
by: Teresa S. Latham
Published: (2025-01-01) -
Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial
by: Vincent Mboizi, et al.
Published: (2024-12-01)